Erowid References Database
|
Wood KE.
“Reply to Fantegrossi et al”.
J Pediatr. 2013 Oct 16.
|
|
Abstract
Thank you for responding to my recent report. I agree that the nomenclature for these types of drugs is confusing and that the data available through the National Poison Control Data System and American Association of Poison Control Centers have inherent limitations. These limitations were acknowledged in the analysis and are clearly described by the American Association of Poison Control Centers.
The purpose of this analysis was to describe overall trends in the exposure to these types of substances and to report the shared characteristics of cases that have been reported to US poison control centers. I sought to increase awareness of these newly emerged drugs and their serious and potentially life-threatening side effects.
Although brand name terminology is always problematic and the changing and unreliable composition of these substances makes precise reporting nearly impossible, I believe that marketing names, including “K2” and “bath salts,” are the most likely terms that the users of these drugs will use when they come to medical attention. The National Poison Control Data System dataset includes the codes “THC homolog” and “bath salts.” Even though these terms are not chemically precise and may create confusion with approved medications and household items, the analysis clearly demonstrates that the use of these terms in poison center reporting is increasing.
I suspect that Fantegrossi et al and I share a similar goal of trying to improve awareness and knowledge of these substances. My analysis and report of exposures adds to this knowledge base. Hopefully, increasing awareness will lead to both better medical care for exposed patients and better precision in laboratory and reporting methods.
|
| # |
| Submit Comment |
|
[
Cite HTML ]
